Yabao Pharmaceutical Group Co Ltd (600351) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.047x

Based on the latest financial reports, Yabao Pharmaceutical Group Co Ltd (600351) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥129.49 Million ≈ $18.95 Million USD) by net assets (CN¥2.76 Billion ≈ $403.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yabao Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Yabao Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Yabao Pharmaceutical Group Co Ltd carry for a breakdown of total debt and financial obligations.

Yabao Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yabao Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Getein Biotech Inc SHG:603387	0.036x
Banco do Estado do Rio Grande do Sul S.A SA:BRSR3	0.283x
Shenzhen Refond Optoelectronics Co Ltd SHE:300241	0.014x
Media and Games Invest PLC XETRA:M8G	0.001x
SmartFinancial, Inc. NYSE:SMBK	0.031x
Ocean’s King Lighting Science & Technology Co Ltd SHE:002724	-0.003x
Garware Technical Fibres Limited NSE:GARFIBRES	0.005x
Alto Neuroscience, Inc. NYSE:ANRO	-0.076x

Annual Cash Flow Conversion Efficiency for Yabao Pharmaceutical Group Co Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see 600351 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.89 Billion ≈ $423.62 Million	CN¥471.69 Million ≈ $69.02 Million	0.163x	-1.98%
2023-12-31	CN¥2.99 Billion ≈ $438.01 Million	CN¥497.55 Million ≈ $72.81 Million	0.166x	+8.54%
2022-12-31	CN¥3.01 Billion ≈ $439.97 Million	CN¥460.46 Million ≈ $67.38 Million	0.153x	+3.74%
2021-12-31	CN¥2.96 Billion ≈ $433.67 Million	CN¥437.50 Million ≈ $64.02 Million	0.148x	+9.21%
2020-12-31	CN¥2.82 Billion ≈ $412.41 Million	CN¥380.96 Million ≈ $55.75 Million	0.135x	-13.38%
2019-12-31	CN¥2.72 Billion ≈ $398.67 Million	CN¥425.17 Million ≈ $62.22 Million	0.156x	+10.21%
2018-12-31	CN¥3.01 Billion ≈ $440.86 Million	CN¥426.60 Million ≈ $62.43 Million	0.142x	+155.17%
2017-12-31	CN¥2.91 Billion ≈ $426.47 Million	CN¥161.73 Million ≈ $23.67 Million	0.055x	-2.85%
2016-12-31	CN¥2.73 Billion ≈ $399.54 Million	CN¥155.95 Million ≈ $22.82 Million	0.057x	+6.62%
2015-12-31	CN¥2.68 Billion ≈ $391.88 Million	CN¥143.47 Million ≈ $20.99 Million	0.054x	-45.42%
2014-12-31	CN¥1.82 Billion ≈ $266.31 Million	CN¥178.63 Million ≈ $26.14 Million	0.098x	+193.10%
2013-12-31	CN¥1.70 Billion ≈ $248.21 Million	CN¥56.80 Million ≈ $8.31 Million	0.033x	+155.92%
2012-12-31	CN¥1.62 Billion ≈ $236.39 Million	CN¥-96.73 Million ≈ $-14.15 Million	-0.060x	-270.37%
2011-12-31	CN¥1.16 Billion ≈ $169.56 Million	CN¥40.73 Million ≈ $5.96 Million	0.035x	+89.80%
2010-12-31	CN¥1.00 Billion ≈ $146.71 Million	CN¥18.57 Million ≈ $2.72 Million	0.019x	-95.48%
2009-12-31	CN¥899.55 Million ≈ $131.63 Million	CN¥368.56 Million ≈ $53.93 Million	0.410x	+230.61%
2008-12-31	CN¥830.32 Million ≈ $121.50 Million	CN¥102.90 Million ≈ $15.06 Million	0.124x	-55.43%
2007-12-31	CN¥380.08 Million ≈ $55.62 Million	CN¥105.69 Million ≈ $15.47 Million	0.278x	+702.54%
2006-12-31	CN¥334.54 Million ≈ $48.95 Million	CN¥11.59 Million ≈ $1.70 Million	0.035x	-53.49%
2005-12-31	CN¥354.37 Million ≈ $51.86 Million	CN¥26.40 Million ≈ $3.86 Million	0.074x	-68.41%
2004-12-31	CN¥338.16 Million ≈ $49.48 Million	CN¥79.73 Million ≈ $11.67 Million	0.236x	+879.94%
2003-12-31	CN¥318.26 Million ≈ $46.57 Million	CN¥-9.62 Million ≈ $-1.41 Million	-0.030x	-134.57%
2002-12-31	CN¥277.81 Million ≈ $40.65 Million	CN¥24.29 Million ≈ $3.55 Million	0.087x	-65.96%
2001-12-31	CN¥91.84 Million ≈ $13.44 Million	CN¥23.59 Million ≈ $3.45 Million	0.257x	--

About Yabao Pharmaceutical Group Co Ltd

SHG:600351 China Drug Manufacturers - Specialty & Generic

Market Cap

$715.92 Million

CN¥4.89 Billion CNY

Market Cap Rank

#10801 Global

#3184 in China

Share Price

CN¥7.07

Change (1 day)

-0.14%

52-Week Range

CN¥5.92 - CN¥8.01

All Time High

CN¥14.53